ABSTRACT. The molecular basis by which fungal and mammalian prions arise spontaneously is poorly understood. A number of different environmental stress conditions are known to increase the frequency of yeast [PSI C ] prion formation in agreement with the idea that conditions which cause protein misfolding may promote the conversion of normally soluble proteins to their amyloid forms. A recent study from our laboratory has shown that the de novo formation of the [PSI C ] prion is significantly increased in yeast mutants lacking key antioxidants suggesting that endogenous reactive oxygen species are sufficient to promote prion formation. Our findings strongly implicate oxidative damage of Sup35 as an important trigger for the formation of the heritable [PSI C ] prion in yeast. This review discusses the mechanisms by which the direct oxidation of Sup35 might lead to structural transitions favoring conversion to the transmissible amyloid-like form. This is analogous to various environmental factors which have been proposed to trigger misfolding of the mammalian prion protein (PrP C ) into the aggregated scrapie form (PrP Sc ).
Most cases of prion diseases are sporadic, that is they form spontaneously without any underlying genetic change. The emergence of disease correlates with a novel conformational form (PrP Sc ) of the cellular PrP C protein. 1 This prion form replicates through a cycle of seeded polymerisation and fragmentation and it is assumed that genetic or environmental factors trigger the initial conformational change in the absence of any pre-existing PrP Sc 'seeds'. The mechanism(s) underlying this switch from a normally soluble protein to a misfolded, infectious form are poorly understood. It is important that these mechanism(s) are established if we are to develop effective preventative measures for human and animal amyloidoses.
The initial alternative conformational state may be instigated by spontaneous misfolding events, triggered by mutation, mistranslation, environmental stresses and/or by disruption of the chaperone network. 2, 3 This is a relatively rare event and for example the de novo appearance of yeast [PSI C ] prion formation has been estimated to occur at frequencies ranging between »10 ¡5 -10
¡7
. [3] [4] [5] This frequency can be elevated 1000-fold by overexpression of Sup35, presumably due to the excess Sup35 increasing the possibility for prion seed formation. [6] [7] [8] Additionally, alterations in the protein homeostasis network including mutations in chaperones and the ubiquitin proteasome system can increase the spontaneous rate of [PSI C ] prion formation. 9 This suggests that spontaneous prion formation might arise as a consequence of random protein misfolding events which are normally dealt with by the cellular protein homeostasis systems. Conditions which cause the formation of misfolded or partially folded proteins may therefore promote the conversion of soluble proteins to their amyloid forms and several different environmental stress conditions, including oxidative stress, have been shown to increase the frequency of [PSI C ] prion formation. 10 Further support for oxidative stress conditions playing a role in de novo prion formation has come from the finding that [ ] prion formation is also observed in response to oxidative stress caused by the superoxide anion. 13 However, the superoxide anion can be dismutated to hydrogen peroxide by the activity of superoxide dismutases and both hydrogen peroxide and the superoxide anion are thought to oxidize amino acid residues through the generation of the highly reactive hydroxyl radical. 16 More work will be required to determine the sources and types of ROS which promote protein damage leading to prion formation, which is important since no single oxidant is typical of 'oxidative stress'. 17 An unbiased genome-wide screen for factors which increase [PSI C ] induction did not identify any antioxidants. 10 However, this screen differentiated [PSI C ] formation from nuclear gene mutations by their irreversible elimination in guanidine hydrochloride (GdnHCl). Reversible curability is a well-established genetic criterion for yeast prions 6 and is commonly tested using GdnHCl which blocks the propagation of prions by inhibiting the key ATPase activity of Hsp104, a molecular chaperone that is absolutely required for yeast prion propagation. 18, 19 The gene deletions identified in this screen were all curable at levels above 95% suggesting that they did not cause any increase in nuclear mutations. All of the antioxidant mutants which we have shown increase the frequency of spontaneous [PSI C ] formation also exhibit significantly increased rates of nuclear mutations. 13 ROS are a well-known cause of DNA damage resulting in increased rates of mutagenesis and genomic instability. For example, loss of TSA1 results in an increased rate of spontaneous mutations which arise as a result of endogenous ROS production. 20 However, there does not appear to be any correlation between the frequency of nuclear mutations and the frequency of [PSI C ] prion formation in antioxidant mutants. 13 
METHIONINE OXIDATION TRIGGERS [PSI

C
] PRION FORMATION
All amino acids are potential targets for oxidation, but methionine residues are particularly sensitive forming a racemic mixture of methionine-S-sulphoxide and methionine-R-sulphoxide in cells. 21 Oxidation converts the moderately hydrophobic thioester side chain of methionine into the hydrophilic sulphoxide form (MetO) which can significantly influence protein folding and structure (Fig. 1A) . Methionine oxidation can be reversed by the activity of methionine sulfoxide reductases (MSR) and hence methionine oxidation has been proposed to play an antioxidant role in scavenging ROS. 22 A number of proteins have been identified which form MetO in response to oxidative stress, including many examples where oxidation is thought to play a regulatory role modulating protein activity. 23 Thus, MetO formation is increasingly thought of as a reversible post translational modification, as well as a marker of protein oxidative damage.
We have used an anti-MetO antibody to detect methionine oxidation of Sup35. Oxidative stress conditions induced by exposure to hydrogen peroxide or the superoxide anion significantly increased MetO levels and increased
13 Similar increases in MetO levels were detected in antioxidant mutants, including mutants deficient in superoxide dismutases, catalases and peroxiredoxins, which all display increased [PSI C ] prion formation. Increased MetO levels were detected in Sup35 from antioxidant mutants grown under normal non-stress conditions indicating that endogenous ROS levels are sufficient to promote Sup35 oxidation. Increased methionine oxidation is commonly detected in a number of disease states as well as during the aging process. For example, MetO antibodies have been used to detect increased methionine oxidation in aged mouse samples and samples from patients with Alzheimer's disease. 24 The MetO content of proteins is also known to increase with age in various model systems. 25 Thus, increased MetO content appears to be a common feature of oxidative stress conditions during various pathological conditions.
It is not know which methionine residues in Sup35 are important for [PSI C ] prion formation. Sup35 has 3 functional regions: an N-terminal region (residues 1-123) which is essential for prion formation, a highly charged middle (M) region (residues 124-253) and a Cterminal region (residues 254-685) which is required for translation termination activity.
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Sup35 contains a total of 19 Met residues including its N-terminal Met residue (Fig. 1B) . The N and M regions contain no Met residues, but the M region is flanked by Met residues. Although the C domain of Sup35 does not form the [PSI C ] prion in the absence of the NM region, oxidation of Met residues in the C domain might be expected to affect the overall protein structure/folding of Sup35 which in turn might promote the formation of misfolded structures that have a higher propensity to switch to the prion conformation. Alternatively Met mutations may affect specific Sup35-chaperone interactions. For example, the M region interacts with Hsp104 and is required for prion curing but not propagation.
27 Several chaperones are known to modulate de novo [PSI C ] prion formation, although the molecular details are not well defined. 9 Hence, methionine oxidation and any resulting alterations in Sup35 secondary structure which alter protein-protein interactions may affect prion formation. 32 The transmissible form of the prion is then formed via a 2 stage process which initially involves the formation of non-transmissible extended polymers of the prion protein followed by their fragmentation into shorter transmissible forms that are thought to define the propagon. 30 Our data indicate that while methionine oxidation can promote prion formation, it can be reversed by the activity of MSR enzymes preventing the switch to the heritable prion form. Yeast contains 3 MSR enzymes (fRMsr/MsrA/ MsrB). 33 Overexpression of MsrA protects Sup35 against methionine oxidation and also prevents [PSI C ] prion formation, confirming that Sup35 oxidation can cause the switch from a soluble to an aggregated prion-form of Sup35 in antioxidant mutants. 12, 13 Taking these observations together we propose a model for ROS- ] prion. Sup35 oxidation may cause misfolding by altering the conformation of its polypeptide backbone and decreasing thermal stability, or alternatively, it may disrupt normal Sup35-chaperone interactions. It is unknown whether Sup35 oxidation occurs on the nascent polypeptide chain or in pre-existing Sup35 molecules (Fig. 2) . Interestingly however, Tsa1 and Tsa2 are both ribosome-associated antioxidants where they may localize to protect 260 Grant nascent proteins as well as the protein biosynthetic machinery against oxidation.
HOW DOES OXIDATIVE PROTEIN DAMAGE PROMOTE [PSI
11,34
Under normal non-stress growth conditions, MetO formation is not detected in Sup35 suggesting that cellular antioxidants are sufficient to protect against endogenous ROS exposure and MSR enzymes function to reduce any MetO that might be formed. The addition of an exogenous oxidant, which can overwhelm the cellular antioxidant defense systems, results in Sup35 oxidation and misfolding, prior to targeting to the IPOD where it is converted to the heritable [PSI C ] prion form. Methionine oxidation does not appear to account for the formation of all yeast prions since we were unable to detect methionine oxidation of Rnq1 in a tsa1 tsa2 mutant. 12 However, the frequency of [PIN C ] formation is elevated in tsa1 tsa2 and sod1 mutants suggesting that prion formation may be a common phenomenon in antioxidant mutants. 12, 13 The spontaneous frequency of [PIN C ] prion formation is significantly higher than [PSI C ] prion formation 12 and hence it may be difficult to detect methionine oxidation once it has formed the [PIN C ] prion form. Alternatively, other forms of protein oxidation may underlie the switch from soluble Rnq1 to its amyloid form. 
CONFLICTING EVIDENCE LINKING METHIONINE OXIDATION WITH MAMMALIAN PRION FORMATION
Conflicting data has been reported regarding the potential role of methionine oxidation in the aggregation and pathogenicity of mammalian prions. Mass spectrometry was originally used to detect MetO in PrP Sc purified from brain samples; although it was unclear whether oxidation actually occurred in the brain or during the protein purification and analysis protocol. 35 Exposing purified PrP C to an oxidant has been shown to result in methionine oxidation, 36 although other in vitro studies suggested that methionine oxidation of recombinant hamster and mouse PrP C interferes with its conversion into amyloid fibrils. 37 Further in vivo studies showed that MetO (particularly Met213 in humans) could be detected in PrP Sc isolated from brain samples, but not in PrP C , leading to the suggestion that MetO is a specific marker for PrP Sc . 38 Conversely, sensitive mass spectrometry based comparison of Met213 oxidation in PrP C and PrP SC isolated from a hamster-adapted scrapie model found comparable low levels of methionine oxidation suggesting that MetO213 should not be regarded as a prion-specific covalent signature. 39 Assuming that methionine oxidation does occur on the PrP protein in vivo, it raise the question as to whether methionine oxidation underlies the structural switch that converts PrP C to PrP Sc , or is simply a biomarker for PrP SC formation. Specificity for PrP Sc might arise if methionine oxidation requires partial denaturation of PrP C before methionine residues can become oxidized, or else they may be oxidized only after PrP SC forms. None of the existing in vivo studies are able address the importance of methionine oxidation in sporadic PrP SC formation. In vitro studies have attempted to examine the importance of methionine oxidation as a destabilizing event that triggers PrP C misfolding leading to spontaneous prion formation. For example, methionine analogs have been used to correlate the degree of PrP C methionine oxidation with the structural transitions that underlie its conversion to the infectious PrP SC form. 40 More recently, methionine oxidation within the core of PrP C has been shown to reduce its thermal stability, promoting generation of a molten globule fold which is thought to be a key step in the misfolding pathway. 41 Similarly, molecular dynamic simulations have suggested that oxidation of Met213 triggers destabilization of PrP C which can trigger its conversion to the pathogenic PrP SC form. 42, 43 Pseudosulfoxidation mutants have been used to mimic methionine oxidation, confirming that oxidation of surface exposed methionine residues perturbs the PrP C structure resulting in destabilization and misfolding. 44 Interestingly, the D178N variant of PrP C was recently found to be more susceptible to methionine oxidation. 45 This PrP mutant has been linked with the inherited human prion disease fatal famililial insomnia (FFI) and methionine oxidation of D178N PrP C decreased its structural stability, enhanced its aggregation and increased neurotoxicity. This suggests that methionine oxidation can have synergistic effects with other pathogenic mutations in PrP C which cause prion diseases. Further work will be required to establish a causal role for methionine oxidation in PrP misfolding and the formation of toxic oligomers and amyloid plaques. This may occur via PrP C destabilization or PrP SC stabilization such as inhibiting clearance of misfolded forms and favoring misfolding pathways which result in amyloid formation. This will however, be experimentally difficult without the tractability of the yeast model system.
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